New aspects of membranoproliferative glomerulonephritis

New England Journal of Medicine

Volumn 367, Issue 1, 2012, Pages 86-

  Manenti, Lucio ^a   Vaglio, Augusto ^a   Buzio, Carlo ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR H;

ACUTE KIDNEY FAILURE; ANEMIA; ANTIGEN ANTIBODY COMPLEX; FOCAL GLOMERULOSCLEROSIS; GENE MUTATION; GENETIC RISK; GLOMERULONEPHRITIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; LETTER; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MONOCLONAL IMMUNOGLOBULINEMIA; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTOPENIA;

ANTIBODIES, MONOCLONAL, HUMANIZED; COMPLEMENT C5; COMPLEMENT PATHWAY, ALTERNATIVE; COMPLEMENT SYSTEM PROTEINS; FEMALE; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS;

EID: 84863518388     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1203660     Document Type: Letter

References (4)

1. Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis - a new look to an old entity. N Engl J Med 2012;366:1119-31.
2. Radhakrishnan S, Lunn A, Kirschfink M, et al. Eculizumab and refractory membranoproliferative glomerulonephritis. N Engl J Med 2012;366:1165-6.
3. Vaziri-Sani F, Holmberg L, Sjöholm AG, et al. Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome. Kidney Int 2006;69:981-8. (Pubitemid 43372172)
4. Lorcy N, Rioux-Leclercq N, Lombard ML, Le Pogamp P, Vigneau C. Three kidneys, two diseases, one antibody? Nephrol Dial Transplant 2011;26:3811-3.